Medical X-ray Market Research Report Forecast till 2030
상품코드:1452458
리서치사:Market Research Future
발행일:2024년 03월
페이지 정보:영문 148 Pages
라이선스 & 가격 (부가세 별도)
한글목차
의료용 X선 시장 규모는 예측 기간 동안 5.20%의 CAGR을 기록할 것으로 예상됩니다.
시장 성장에 기여하는 요인은 진행 중인 전염병의 확산, 조기 분석에 대한 인식의 증가입니다.
의료용 X선 시장은 전염병의 지속적인 유행으로 인해 크게 성장하고 있습니다. 심혈관 질환, 악성 종양, 호흡기 질환과 같은 만성 질환도 전 세계적으로 문제가 되고 있습니다. 이러한 질병의 증가로 인해 X선 영상을 포함한 최첨단 증상 치료 장비에 대한 관심이 증가하고 있으며, X선 기술의 혁신은 질병의 조기 발견에 중요한 역할을하고 의료 서비스 전문가가 편리하고 정확한 치료를 수행할 수 있도록 도와줍니다. 또한, X선은 유연성이 뛰어나고 내부 구조의 상세한 이미지를 포착할 수 있어 의료 현장에서 필수적인 역할을 하고 있습니다.
세계의 의료용 X선 시장을 조사했으며, 시장의 정의와 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추이와 예측, 각종 부문별·지역별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 조사 방법
제4장 시장 역학
성장 촉진요인
성장 억제요인
기회
제5장 시장 요인 분석
밸류체인 분석
Porter's Five Forces 모델
COVID-19가 세계의 의료용 X선 시장에 미치는 영향
제6장 세계의 의료용 X선 시장 : 유형별
개요
디지털 X선 촬영
컴퓨터 X선 촬영
제7장 세계의 의료용 X선 시장 : 컴포넌트별
개요
애노드
캐소드
드라이브 컴포넌트
실드·필터
제8장 세계의 의료용 X선 시장 : 모빌리티별
개요
고정형
휴대형
제9장 세계의 의료용 X선 시장 : 용도별
개요
치과
심혈관계
수의
정형외과
맘모그래피
기타
제10장 세계의 의료용 X선 시장 : 최종사용자별
개요
병원·진료소
영상 진단 센터
기타
제11장 세계의 의료용 X선 시장 : 지역별
세계
북미
유럽
아시아태평양
기타 지역
제12장 경쟁 상황
개요
경쟁 벤치마킹
세계 X선 시장의 주요 성장 전략
개발 건수에서의 리더 기업
주요 개발 분석
주요 전개·성장 전략
재무 매트릭스
제13장 기업 개요
GE HEALTHCARE
SIEMENS
KONINKLIJKE PHILIPS N.V.
FUJIFILM CORPORATION
PLANSEE SE
SHIMADZU CORPORATION
HOLOGIC, INC
ALLENGERS
ADONIS MEDICAL SYSTEMS PVT LTD
ASPEN IMAGING HEALTHCARE
제14장 부록
ksm
영문 목차
영문목차
Market Overview
The Medical X-ray Market is expected to register a CAGR of 5.20% during the review period.
The elements adding to the development of market are expanding pervasiveness of ongoing infections and rising consciousness of early analysis.
The medical X-ray market is experiencing a critical lift because of the rising pervasiveness of ongoing infections. Constant infections, like cardiovascular issues, malignant growth, and respiratory circumstances, have turned into a developing concern around the world. In 2022, as per the Habitats for Infectious prevention and Anticipation (CDC) practically 60% of grown-up Americans experience the ill effects of no less than one constant sickness. Persistent illnesses like diabetes, malignant growth, and cardiovascular sickness are the main sources of death in the US, and individuals with constant sicknesses and emotional wellness conditions represent 90% of the country's USD 3.8 trillion in yearly medical services costs. This ascent in persistent sicknesses has encouraged a more noteworthy interest for cutting edge symptomatic devices, including X-ray imaging. X-ray innovation assumes a significant part in the early discovery, conclusion, and checking of these circumstances, empowering medical services experts to give convenient and exact therapy. The flexibility and viability of X-rays in catching itemized pictures of inward designs make them imperative in medical care settings.
Besides, the rising consciousness of the significance of early finding is a huge driver for the development of the medical X-ray market. Lately, there has been a developing accentuation on the early location and convenient administration of infections. The capacity of X-ray innovation to give fast and exact demonstrative imaging assumes an essential part in such manner.
Market Segmentation
Based on type, the Medical X-ray Market has been segmented into digital radiography and computed radiography. Based on component, the Market is classified into anodes, cathodes, drive components, and shieldings and filters. The mobility segment is made up of stationary and mobile.
The applications of Medical X- Ray market includes dental, cardiovascular, veterinary, orthopedics, mammography, and others. In terms of end user, the market is divided into hospitals & clinics, diagnostic imaging centers, and others.
Regional Insights
The presence of dynamic industry players and the accessibility of the items are expanding the market's development in the North America. Furthermore, increasing commonness of constant illnesses, like cardiovascular sicknesses, malignant growth, and respiratory problems among others in North America.
Europe represents the second-biggest market share because of the availability to cutting edge analysis and therapy offices, the rising improvement of cutting-edge creative X-ray innovations, like DR and Cone-Bar Registered Tomography (CBCT), and the rising weight of persistent sicknesses and the ensuing interest for cutting edge analytic imaging. Moreover, developing medical services expenditure is additionally expected to help the development of the market.
The medical X-ray market in Asia-Pacific is expected to enroll the fastest development rate owing to the developing medical services foundation, developing speculation by key part with neighborhoods producers, and developing wellbeing mindfulness among the populace. Moreover, mechanical headways in medical X-ray frameworks and an ascent in item improvement with cutting edge elements like Man-made reasoning (computer-based intelligence) combination, portion streamlining calculations, and upgraded picture handling capacities help the market development.
Major Players
Key Companies in the Medical X-ray Market are Koninklijke Philips N.V. (US), GE Healthcare (US), Aspen Imaging Healthcare (US), Fujifilm Corporation (Japan), Siemens Healthineers (Germany), Allengers Medical Systems Ltd (India), Hologic, Inc. (US), Adonis Medical System (India), and Plansee SE (US).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.1.1 MARKET SYNOPSIS
2 MARKET INTRODUCTIONS
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 LIST OF ASSUMPTIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 RISING AWARENESS OF EARLY DIAGNOSIS
4.2.3 GROWING AGING POPULATION
4.3 RESTRAINTS
4.3.1 COMPETITION FROM ALTERNATIVE IMAGING MODALITIES
4.4 OPPORTUNITY
4.4.1 INCREASING DEMAND FOR POINT-OF-CARE IMAGING
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D & DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL X- RAY MARKET
5.3.1 IMPACT ON COST OF RAW MATERIALS AND PRODUCTS
5.3.2 IMPACT ON AVAILABILITY OF PRODUCTS
5.3.3 IMPACT ON PRODUCTION OF MAJOR MANUFACTURERS
5.3.4 IMPACT ON TRADE (IMPORT/EXPORT)
6 GLOBAL MEDICAL X-RAY MARKET, BY TYPE
6.1 OVERVIEW
6.2 DIGITAL RADIOGRAPHY
6.3 COMPUTED RADIOGRAPHY
7 GLOBAL MEDICAL X-RAY MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 ANODES
7.3 CATHODES
7.4 DRIVE COMPONENTS
7.5 SHIELDINGS AND FILTERS
8 GLOBAL MEDICAL X-RAY MARKET, BY MOBILITY
8.1 OVERVIEW
8.2 STATIONARY
8.3 MOBILE
9 GLOBAL MEDICAL X-RAY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DENTAL
9.3 CARDIOVASCULAR
9.4 VETERINARY
9.5 ORTHOPEDICS
9.6 MAMMOGRAPHY
9.7 OTHERS
10 GLOBAL MEDICAL X-RAY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS & CLINICS
10.3 DIAGNOSTIC IMAGING CENTERS
10.4 OTHERS
11 GLOBAL MEDICAL X-RAY MARKET, BY REGION
11.1 GLOBAL
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 INDIA
11.4.3 JAPAN
11.4.4 SOUTH KOREA
11.4.5 AUSTRALIA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 MIDDLE EAST
11.5.2 AFRICA
11.5.3 LATIN AMERICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL X-RAY MARKET
12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL X-RAY MARKET
12.5 KEY DEVELOPMENT ANALYSIS
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.6.1 PRODUCT/SERVICE LAUNCH/ PRODUCT APPROVAL
12.6.2 PARTNERSHIP/COLLABORATION/AGREEMENT
12.7 FINANCIAL MATRIX
12.7.1 SALES (USD BILLION), 2022
12.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD BILLION), 2022
